Visible node/edge number:
Node colors:
Node labels:

show label of nodes with degree >=

Node sizes:
Edge colors:
Edge widths factor:
Layout:

gravity >=

edgeLength =

GRN in network:

Notice: IE browser need to manually refresh (F5) this page after resetting the network.

This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.

"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.

miRNA-gene regulations

(Download full result)

Num microRNA           Gene miRNA log2FC miRNA pvalue Gene log2FC Gene pvalue Interaction Correlation beta Correlation P-value PMID Reported in cancer studies
1 hsa-miR-200b-3p ABCA1 -1.7 0 1.48 0 TargetScan -0.37 0 NA
2 hsa-miR-429 ABCA1 -2.17 0 1.48 0 miRNATAP -0.35 0 NA
3 hsa-miR-429 ABCB4 -2.17 0 1.58 0 miRanda -0.35 0 NA
4 hsa-miR-429 ABCB5 -2.17 0 0.86 0.01229 miRanda -0.21 0.03446 NA
5 hsa-miR-101-3p ABCC5 0.68 0 -0.63 0 MirTarget; miRNATAP -0.24 0.0001 NA
6 hsa-miR-429 ABCD2 -2.17 0 0.83 3.0E-5 miRanda -0.25 1.0E-5 NA
7 hsa-miR-101-3p ABI2 0.68 0 -0.56 0 miRNATAP -0.15 0.00011 NA
8 hsa-miR-200b-3p ABL2 -1.7 0 0.74 0 MirTarget -0.24 0 NA
9 hsa-miR-429 ABL2 -2.17 0 0.74 0 MirTarget -0.22 0 NA
10 hsa-miR-101-3p ABTB2 0.68 0 -2.15 0 miRNATAP -0.7 0 NA
11 hsa-miR-144-3p ABTB2 1.46 0 -2.15 0 miRNATAP -0.24 0 NA
12 hsa-miR-429 ACAD11 -2.17 0 1.27 0 miRanda -0.18 0.00045 NA
13 hsa-miR-200b-3p ACAP2 -1.7 0 0.21 0.00194 mirMAP -0.11 0 NA
14 hsa-miR-429 ACE -2.17 0 1.62 0 miRanda -0.39 0 NA
15 hsa-miR-532-3p ACHE -1.76 0 0.5 0.02002 miRNATAP -0.23 0.00423 NA
16 hsa-miR-532-3p ACRBP -1.76 0 1.28 0 miRNATAP -0.37 0 NA
17 hsa-miR-101-3p ACSL4 0.68 0 -1.51 0 miRNATAP -0.59 0 NA
18 hsa-miR-144-3p ACSL4 1.46 0 -1.51 0 MirTarget; miRNATAP -0.15 0 NA
19 hsa-miR-429 ACTN1 -2.17 0 0.73 0 miRanda -0.23 0 NA
20 hsa-miR-532-3p ACTN1 -1.76 0 0.73 0 miRNATAP -0.29 0 NA
21 hsa-miR-429 ACVRL1 -2.17 0 0.72 0 miRNATAP -0.17 0 NA
22 hsa-miR-429 ADAM11 -2.17 0 1.69 0 miRNATAP -0.38 0 NA
23 hsa-miR-429 ADAM12 -2.17 0 1.67 0 miRanda; miRNATAP -0.58 0 NA
24 hsa-miR-429 ADAM19 -2.17 0 1.49 0 miRanda; miRNATAP -0.44 0 NA
25 hsa-miR-429 ADAM28 -2.17 0 1.21 0 miRanda -0.19 3.0E-5 NA
26 hsa-miR-429 ADAM9 -2.17 0 0.34 0.00065 miRanda -0.11 6.0E-5 NA
27 hsa-miR-429 ADAMDEC1 -2.17 0 5.01 0 miRanda -1.04 0 NA
28 hsa-miR-429 ADAMTS10 -2.17 0 1.97 0 miRNATAP -0.37 0 NA
29 hsa-miR-200b-3p ADAMTS12 -1.7 0 0.68 0.00313 mirMAP -0.56 0 NA
30 hsa-miR-144-3p ADAMTS15 1.46 0 -2.45 0 MirTarget; miRNATAP -0.14 0.0131 NA
31 hsa-miR-429 ADAMTS18 -2.17 0 1.09 0 miRanda; miRNATAP -0.31 0 NA
32 hsa-miR-429 ADAMTS2 -2.17 0 1.6 0 miRNATAP -0.45 0 NA
33 hsa-miR-532-3p ADAMTS2 -1.76 0 1.6 0 mirMAP -0.51 0 NA
34 hsa-miR-429 ADAMTS4 -2.17 0 2.68 0 miRanda -0.63 0 NA
35 hsa-miR-200b-3p ADAMTS5 -1.7 0 0.66 0 mirMAP -0.22 0 NA
36 hsa-miR-429 ADAP2 -2.17 0 1.91 0 miRanda -0.38 0 NA
37 hsa-miR-200b-3p ADCY2 -1.7 0 1.55 0 MirTarget; TargetScan -0.33 0.00437 NA
38 hsa-miR-429 ADCY2 -2.17 0 1.55 0 MirTarget; PITA; miRanda; miRNATAP -0.25 0.01244 NA
39 hsa-miR-429 ADCY7 -2.17 0 1.81 0 miRanda -0.34 0 NA
40 hsa-miR-101-3p ADO 0.68 0 -0.27 0 miRNAWalker2 validate -0.16 0 NA
41 hsa-miR-429 ADORA3 -2.17 0 3.22 0 miRNATAP -0.59 0 NA
42 hsa-miR-429 AFF2 -2.17 0 0.98 0 miRNATAP -0.2 0.00055 NA
43 hsa-miR-532-3p AFF2 -1.76 0 0.98 0 miRNATAP -0.4 0 NA
44 hsa-miR-200b-3p AFF3 -1.7 0 1.16 0 MirTarget; TargetScan -0.35 0 NA
45 hsa-miR-429 AFF3 -2.17 0 1.16 0 MirTarget; PITA; miRanda; miRNATAP -0.31 0 NA
46 hsa-miR-429 AGAP2 -2.17 0 3.18 0 miRNATAP -0.63 0 NA
47 hsa-miR-429 AGAP3 -2.17 0 0.95 0 miRNATAP -0.16 0 NA
48 hsa-miR-101-3p AGFG1 0.68 0 -0.13 0.03092 MirTarget -0.17 0 NA
49 hsa-miR-429 AHR -2.17 0 0.76 0 miRanda -0.19 0 NA
50 hsa-miR-429 AHRR -2.17 0 0.99 0 miRanda -0.21 8.0E-5 NA
51 hsa-miR-532-3p AHRR -1.76 0 0.99 0 mirMAP -0.43 0 NA
52 hsa-miR-429 AICDA -2.17 0 3.63 0 miRanda; miRNATAP -0.78 0 NA
53 hsa-miR-144-3p AIF1L 1.46 0 -3.57 0 mirMAP -0.28 3.0E-5 NA
54 hsa-miR-200b-3p AKAP13 -1.7 0 0.53 0 mirMAP -0.14 0 NA
55 hsa-miR-429 AKAP13 -2.17 0 0.53 0 miRNATAP -0.13 0 NA
56 hsa-miR-429 AKNA -2.17 0 1.43 0 miRanda -0.26 0 NA
57 hsa-miR-532-3p ALCAM -1.76 0 0.02 0.86953 MirTarget; PITA; miRNATAP -0.11 0.00322 NA
58 hsa-miR-101-3p ALDH1A3 0.68 0 -1.23 0 miRNATAP -0.92 0 NA
59 hsa-miR-144-3p ALDH1A3 1.46 0 -1.23 0 miRNATAP -0.19 0.00046 NA
60 hsa-miR-429 ALDH1L2 -2.17 0 0.98 0 miRanda -0.35 0 NA
61 hsa-miR-532-3p AMDHD2 -1.76 0 0.81 0 mirMAP -0.17 0.00076 NA
62 hsa-miR-101-3p AMMECR1 0.68 0 -0.31 0 miRNATAP -0.25 0 NA
63 hsa-miR-429 ANGPT2 -2.17 0 3.23 0 miRanda -0.72 0 NA
64 hsa-miR-101-3p ANK2 0.68 0 -2.68 0 miRNATAP -0.86 0 NA
65 hsa-miR-144-3p ANK2 1.46 0 -2.68 0 miRNATAP -0.14 0.0168 NA
66 hsa-miR-429 ANKDD1A -2.17 0 0.82 0 miRanda -0.14 2.0E-5 NA
67 hsa-miR-101-3p ANKFY1 0.68 0 -0.44 0 miRNAWalker2 validate -0.13 0.00023 NA
68 hsa-miR-200b-3p ANKH -1.7 0 0.06 0.44279 TargetScan -0.14 0 NA
69 hsa-miR-429 ANKH -2.17 0 0.06 0.44279 PITA; miRanda; miRNATAP -0.11 0 NA
70 hsa-miR-429 ANKRD13B -2.17 0 1.36 0 miRNATAP -0.3 0 NA
71 hsa-miR-429 ANKRD34A -2.17 0 0.57 0 miRanda -0.15 0 NA
72 hsa-miR-429 ANKRD36B -2.17 0 1.11 0 miRanda -0.2 4.0E-5 NA
73 hsa-miR-429 ANKRD37 -2.17 0 1.44 0 miRanda -0.2 0 NA
74 hsa-miR-101-3p ANKRD52 0.68 0 -0.53 0 miRNATAP -0.17 6.0E-5 NA
75 hsa-miR-200b-3p ANLN -1.7 0 2.52 0 MirTarget; TargetScan -0.67 0 NA
76 hsa-miR-429 ANLN -2.17 0 2.52 0 MirTarget; PITA; miRanda; miRNATAP -0.61 0 NA
77 hsa-miR-429 ANO6 -2.17 0 0.26 0.00056 miRanda -0.12 0 NA
78 hsa-miR-200b-3p ANP32B -1.7 0 0.27 0 TargetScan -0.13 0 NA
79 hsa-miR-429 ANTXR2 -2.17 0 0.22 0.02031 miRNATAP -0.15 0 NA
80 hsa-miR-429 ANXA4 -2.17 0 1.77 0 miRanda -0.26 0 NA
81 hsa-miR-101-3p AP1G1 0.68 0 -0.6 0 miRNAWalker2 validate; miRNATAP -0.15 0.00017 NA
82 hsa-miR-200b-3p AP1S2 -1.7 0 0.78 0 MirTarget; TargetScan -0.26 0 NA
83 hsa-miR-429 AP1S2 -2.17 0 0.78 0 MirTarget; PITA; miRanda; miRNATAP -0.23 0 NA
84 hsa-miR-101-3p AP1S3 0.68 0 -0.34 0.00376 miRNAWalker2 validate -0.22 0.00237 NA
85 hsa-miR-101-3p AP3M1 0.68 0 -0.33 0 miRNAWalker2 validate -0.14 1.0E-5 NA
86 hsa-miR-429 AP3S1 -2.17 0 1.02 0 miRanda -0.24 0 NA
87 hsa-miR-101-3p AP3S2 0.68 0 -0.46 0 mirMAP -0.12 0.00063 NA
88 hsa-miR-200b-3p APAF1 -1.7 0 0.44 0 TargetScan -0.11 0 NA
89 hsa-miR-429 APAF1 -2.17 0 0.44 0 PITA; miRanda; miRNATAP -0.12 0 NA
90 hsa-miR-429 APBB3 -2.17 0 1.11 0 miRanda -0.16 7.0E-5 NA
91 hsa-miR-429 APLN -2.17 0 2.47 0 miRNATAP -0.46 0 NA
92 hsa-miR-101-3p APP 0.68 0 -0.67 0 miRNAWalker2 validate; miRTarBase; miRNATAP -0.2 6.0E-5 NA
93 hsa-miR-429 AREG -2.17 0 1.08 0 miRanda -0.27 6.0E-5 NA
94 hsa-miR-429 ARHGAP1 -2.17 0 0.5 0 miRNATAP -0.1 0 NA
95 hsa-miR-429 ARHGAP10 -2.17 0 0.45 0 miRanda -0.1 0 NA
96 hsa-miR-429 ARHGAP11B -2.17 0 1.89 0 miRanda -0.46 0 NA
97 hsa-miR-429 ARHGAP15 -2.17 0 1.95 0 miRanda -0.37 0 NA
98 hsa-miR-429 ARHGAP17 -2.17 0 0.64 0 miRanda -0.14 0 NA
99 hsa-miR-200b-3p ARHGAP20 -1.7 0 0.06 0.68409 MirTarget; TargetScan -0.21 8.0E-5 NA
100 hsa-miR-429 ARHGAP20 -2.17 0 0.06 0.68409 MirTarget; miRanda; miRNATAP -0.16 0.00042 NA
101 hsa-miR-429 ARHGAP25 -2.17 0 1.75 0 miRNATAP -0.35 0 NA
102 hsa-miR-200b-3p ARHGAP26 -1.7 0 1.01 0 TargetScan -0.2 0 NA
103 hsa-miR-429 ARHGAP26 -2.17 0 1.01 0 PITA; miRNATAP -0.19 0 NA
104 hsa-miR-532-3p ARHGAP26 -1.76 0 1.01 0 mirMAP -0.21 0 NA
105 hsa-miR-200b-3p ARHGDIA -1.7 0 0.4 0 MirTarget; TargetScan -0.11 3.0E-5 NA
106 hsa-miR-200b-3p ARHGEF1 -1.7 0 1.07 0 TargetScan -0.24 0 NA
107 hsa-miR-429 ARHGEF1 -2.17 0 1.07 0 miRanda; miRNATAP -0.19 0 NA
108 hsa-miR-429 ARHGEF10 -2.17 0 0.86 0 miRanda -0.22 0 NA
109 hsa-miR-200b-3p ARHGEF17 -1.7 0 0.44 0 TargetScan -0.12 0.0001 NA
110 hsa-miR-429 ARHGEF17 -2.17 0 0.44 0 PITA; miRanda; miRNATAP -0.1 0.0001 NA
111 hsa-miR-429 ARHGEF2 -2.17 0 0.47 0 miRNATAP -0.12 0 NA
112 hsa-miR-101-3p ARHGEF3 0.68 0 -1.06 0 MirTarget -0.15 0.01243 NA
113 hsa-miR-200b-3p ARHGEF6 -1.7 0 1.16 0 mirMAP -0.28 0 NA
114 hsa-miR-429 ARHGEF6 -2.17 0 1.16 0 miRanda; mirMAP -0.28 0 NA
115 hsa-miR-429 ARHGEF7 -2.17 0 0.61 0 miRNATAP -0.11 0 NA
116 hsa-miR-101-3p ARID1A 0.68 0 -0.42 0 miRNAWalker2 validate; MirTarget; miRNATAP -0.12 0.0013 NA
117 hsa-miR-200b-3p ARL10 -1.7 0 0.82 0 mirMAP -0.11 0.02477 NA
118 hsa-miR-429 ARL10 -2.17 0 0.82 0 mirMAP -0.14 0.00056 NA
119 hsa-miR-429 ARL4A -2.17 0 1.07 0 miRanda; miRNATAP -0.28 0 NA
120 hsa-miR-429 ARL4C -2.17 0 1.68 0 miRNATAP -0.39 0 NA
121 hsa-miR-200b-3p ARL6IP6 -1.7 0 0.66 0 TargetScan -0.21 0 NA
122 hsa-miR-429 ARL6IP6 -2.17 0 0.66 0 miRanda -0.19 0 NA
123 hsa-miR-101-3p ARRDC3 0.68 0 0.27 0.025 miRNATAP -0.2 0.00769 NA
124 hsa-miR-200b-3p ARRDC3 -1.7 0 0.27 0.025 TargetScan -0.12 0.00255 NA
125 hsa-miR-429 ARRDC3 -2.17 0 0.27 0.025 PITA; miRanda; miRNATAP -0.15 2.0E-5 NA
126 hsa-miR-200b-3p ASAP1 -1.7 0 1.03 0 MirTarget; TargetScan -0.31 0 NA
127 hsa-miR-429 ASAP1 -2.17 0 1.03 0 MirTarget; miRanda; miRNATAP -0.27 0 NA
128 hsa-miR-429 ASCC3 -2.17 0 0.31 0.0001 miRanda -0.1 0 NA
129 hsa-miR-101-3p ASPN 0.68 0 -0.52 0.00472 MirTarget; miRNATAP -0.5 1.0E-5 NA
130 hsa-miR-429 ATAD2 -2.17 0 0.83 0 miRanda -0.25 0 NA
131 hsa-miR-200b-3p ATF7 -1.7 0 0.3 0 mirMAP -0.11 0 NA
132 hsa-miR-429 ATF7 -2.17 0 0.3 0 miRanda; miRNATAP -0.11 0 NA
133 hsa-miR-429 ATG12 -2.17 0 0.87 0 miRanda; miRNATAP -0.23 0 NA
134 hsa-miR-429 ATG16L1 -2.17 0 0.74 0 miRNATAP -0.12 2.0E-5 NA
135 hsa-miR-429 ATP11A -2.17 0 1.32 0 miRNATAP -0.21 0 NA
136 hsa-miR-532-3p ATP13A3 -1.76 0 0.27 0.00201 miRNATAP -0.11 0.00046 NA
137 hsa-miR-101-3p ATP1B1 0.68 0 -1.41 0 miRNATAP -0.25 0.0012 NA
138 hsa-miR-101-3p ATP2B1 0.68 0 -0.4 0 miRNATAP -0.25 0 NA
139 hsa-miR-429 ATP2B2 -2.17 0 3.14 0 miRanda; miRNATAP -0.55 0 NA
140 hsa-miR-101-3p ATP5B 0.68 0 -1.06 0 miRNAWalker2 validate; miRTarBase -0.25 2.0E-5 NA
141 hsa-miR-101-3p ATRNL1 0.68 0 -3.65 0 MirTarget -1.35 0 NA
142 hsa-miR-101-3p ATRX 0.68 0 -0.52 0 MirTarget; miRNATAP -0.14 0.00256 NA
143 hsa-miR-200b-3p ATXN1 -1.7 0 0.44 0 MirTarget; TargetScan -0.14 0 NA
144 hsa-miR-429 ATXN1 -2.17 0 0.44 0 MirTarget; PITA; miRNATAP -0.13 0 NA
145 hsa-miR-429 ATXN2L -2.17 0 0.66 0 miRNATAP -0.13 0 NA
146 hsa-miR-532-3p ATXN2L -1.76 0 0.66 0 miRNATAP -0.18 0 NA
147 hsa-miR-144-3p AXIN2 1.46 0 -1.42 0 MirTarget -0.15 4.0E-5 NA
148 hsa-miR-101-3p B3GALNT2 0.68 0 -0.39 0 MirTarget -0.17 1.0E-5 NA
149 hsa-miR-200b-3p B3GAT2 -1.7 0 0.81 0 mirMAP -0.14 0.01023 NA
150 hsa-miR-429 B3GAT2 -2.17 0 0.81 0 mirMAP -0.11 0.01762 NA

Over-represented Gene Ontology Biological Process

NumGOOverlapSizeP ValueAdj. P Value
1 REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT 271 1672 6.416e-33 2.986e-29
2 REGULATION OF CELL DIFFERENTIATION 239 1492 4.277e-28 9.951e-25
3 TISSUE DEVELOPMENT 241 1518 9.407e-28 1.459e-24
4 CELL DEVELOPMENT 228 1426 1.196e-26 1.391e-23
5 REGULATION OF CELL PROLIFERATION 230 1496 1.73e-24 1.61e-21
6 LOCOMOTION 185 1114 1.679e-23 1.225e-20
7 NEUROGENESIS 217 1402 1.843e-23 1.225e-20
8 NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 168 983 1.025e-22 5.963e-20
9 MOVEMENT OF CELL OR SUBCELLULAR COMPONENT 199 1275 6.125e-22 2.855e-19
10 CARDIOVASCULAR SYSTEM DEVELOPMENT 143 788 6.75e-22 2.855e-19
11 CIRCULATORY SYSTEM DEVELOPMENT 143 788 6.75e-22 2.855e-19
12 POSITIVE REGULATION OF DEVELOPMENTAL PROCESS 184 1142 7.502e-22 2.909e-19
13 POSITIVE REGULATION OF BIOSYNTHETIC PROCESS 254 1805 1.733e-21 6.203e-19
14 REGULATION OF CELLULAR COMPONENT MOVEMENT 139 771 4.931e-21 1.639e-18
15 REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS 168 1021 6.141e-21 1.905e-18
16 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 209 1395 7.71e-21 2.242e-18
17 POSITIVE REGULATION OF GENE EXPRESSION 244 1733 1.188e-20 3.252e-18
18 BIOLOGICAL ADHESION 168 1032 1.902e-20 4.918e-18
19 IMMUNE SYSTEM PROCESS 267 1984 7.532e-20 1.752e-17
20 REGULATION OF CELL DEVELOPMENT 144 836 7.267e-20 1.752e-17
21 VASCULATURE DEVELOPMENT 98 469 1.356e-19 3.005e-17
22 POSITIVE REGULATION OF RESPONSE TO STIMULUS 260 1929 2.099e-19 4.439e-17
23 REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 232 1656 2.398e-19 4.851e-17
24 BLOOD VESSEL MORPHOGENESIS 82 364 1.205e-18 2.244e-16
25 NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS 137 801 1.161e-18 2.244e-16
26 REGULATION OF NEURON DIFFERENTIATION 106 554 3.776e-18 6.757e-16
27 POSITIVE REGULATION OF CELL DIFFERENTIATION 138 823 4.995e-18 8.609e-16
28 CELL MOTILITY 139 835 7.113e-18 1.141e-15
29 LOCALIZATION OF CELL 139 835 7.113e-18 1.141e-15
30 REGULATION OF NERVOUS SYSTEM DEVELOPMENT 128 750 2.056e-17 3.19e-15
31 CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 99 513 2.773e-17 4.162e-15
32 ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS 151 957 3.528e-17 5.13e-15
33 TISSUE MORPHOGENESIS 101 533 4.794e-17 6.76e-15
34 REGULATION OF CELL ADHESION 112 629 1.03e-16 1.409e-14
35 REGULATION OF CELL DEATH 204 1472 1.667e-16 2.216e-14
36 POSITIVE REGULATION OF CELL COMMUNICATION 210 1532 1.867e-16 2.413e-14
37 REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 234 1784 4.94e-16 6.212e-14
38 ORGAN MORPHOGENESIS 134 841 1.11e-15 1.359e-13
39 NEGATIVE REGULATION OF CELL PROLIFERATION 111 643 1.371e-15 1.636e-13
40 NEGATIVE REGULATION OF RESPONSE TO STIMULUS 189 1360 1.935e-15 2.25e-13
41 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 151 1004 2.509e-15 2.848e-13
42 IMMUNE SYSTEM DEVELOPMENT 103 582 2.822e-15 3.126e-13
43 INTRACELLULAR SIGNAL TRANSDUCTION 210 1572 3.031e-15 3.28e-13
44 NEURON DIFFERENTIATION 136 874 4.61e-15 4.875e-13
45 NEGATIVE REGULATION OF CELL DIFFERENTIATION 105 609 9.063e-15 9.371e-13
46 POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS 200 1492 1.091e-14 1.104e-12
47 POSITIVE REGULATION OF CELL PROLIFERATION 128 814 1.401e-14 1.387e-12
48 CELLULAR RESPONSE TO ORGANIC SUBSTANCE 235 1848 1.46e-14 1.415e-12
49 POSITIVE REGULATION OF CATALYTIC ACTIVITY 202 1518 1.659e-14 1.575e-12
50 POSITIVE REGULATION OF MOLECULAR FUNCTION 229 1791 1.871e-14 1.741e-12
51 CELL CELL ADHESION 104 608 2.083e-14 1.9e-12
52 MUSCLE STRUCTURE DEVELOPMENT 82 432 4.171e-14 3.732e-12
53 EPITHELIUM DEVELOPMENT 141 945 4.328e-14 3.8e-12
54 NEGATIVE REGULATION OF CELL COMMUNICATION 167 1192 5.019e-14 4.325e-12
55 POSITIVE REGULATION OF CELL DEATH 102 605 9.638e-14 8.154e-12
56 REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 69 337 1.046e-13 8.69e-12
57 RESPONSE TO EXTERNAL STIMULUS 229 1821 1.129e-13 9.215e-12
58 EMBRYO DEVELOPMENT 134 894 1.375e-13 1.103e-11
59 REGULATION OF CELL MORPHOGENESIS 95 552 2.001e-13 1.578e-11
60 CELLULAR COMPONENT MORPHOGENESIS 134 900 2.286e-13 1.773e-11
61 RESPONSE TO ENDOGENOUS STIMULUS 191 1450 2.518e-13 1.921e-11
62 REGULATION OF NEURON PROJECTION DEVELOPMENT 77 408 3.44e-13 2.582e-11
63 HEART DEVELOPMENT 84 466 3.972e-13 2.901e-11
64 REGULATION OF PHOSPHORUS METABOLIC PROCESS 207 1618 3.991e-13 2.901e-11
65 REGULATION OF PROTEIN MODIFICATION PROCESS 216 1710 4.11e-13 2.942e-11
66 POSITIVE REGULATION OF CELL DEVELOPMENT 84 472 8.143e-13 5.741e-11
67 MORPHOGENESIS OF AN EPITHELIUM 75 400 9.83e-13 6.827e-11
68 CELL ACTIVATION 95 568 1.133e-12 7.75e-11
69 RESPONSE TO ABIOTIC STIMULUS 145 1024 1.202e-12 8.103e-11
70 SINGLE ORGANISM CELL ADHESION 82 459 1.244e-12 8.268e-11
71 TUBE DEVELOPMENT 93 552 1.285e-12 8.419e-11
72 ANGIOGENESIS 61 293 1.332e-12 8.609e-11
73 POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 129 876 1.467e-12 9.351e-11
74 POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 145 1036 2.948e-12 1.829e-10
75 POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 145 1036 2.948e-12 1.829e-10
76 POSITIVE REGULATION OF HYDROLASE ACTIVITY 131 905 3.373e-12 2.065e-10
77 REGULATION OF IMMUNE SYSTEM PROCESS 182 1403 3.869e-12 2.338e-10
78 NEURON DEVELOPMENT 107 687 4.217e-12 2.516e-10
79 NEGATIVE REGULATION OF LOCOMOTION 56 263 4.301e-12 2.533e-10
80 POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS 154 1135 6.946e-12 4.04e-10
81 RESPONSE TO GROWTH FACTOR 82 475 7.877e-12 4.525e-10
82 CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION 69 368 8.039e-12 4.562e-10
83 NEURON PROJECTION DEVELOPMENT 90 545 9.286e-12 5.206e-10
84 NEURON PROJECTION MORPHOGENESIS 73 402 9.789e-12 5.422e-10
85 UROGENITAL SYSTEM DEVELOPMENT 60 299 1.035e-11 5.668e-10
86 MESENCHYME DEVELOPMENT 45 190 1.27e-11 6.869e-10
87 REGULATION OF CELL PROJECTION ORGANIZATION 91 558 1.437e-11 7.686e-10
88 REGULATION OF HYDROLASE ACTIVITY 172 1327 1.743e-11 9.217e-10
89 EXTRACELLULAR STRUCTURE ORGANIZATION 60 304 2.126e-11 1.111e-09
90 CELLULAR RESPONSE TO ENDOGENOUS STIMULUS 139 1008 2.537e-11 1.312e-09
91 POSITIVE REGULATION OF NEURON DIFFERENTIATION 60 306 2.818e-11 1.441e-09
92 MESENCHYMAL CELL DIFFERENTIATION 36 134 3.079e-11 1.557e-09
93 REGULATION OF EPITHELIAL CELL PROLIFERATION 57 285 3.907e-11 1.955e-09
94 REGULATION OF TRANSPORT 217 1804 4.242e-11 2.1e-09
95 EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING 89 554 5.482e-11 2.685e-09
96 RESPONSE TO WOUNDING 90 563 5.58e-11 2.704e-09
97 POSITIVE REGULATION OF CELL ADHESION 68 376 6.084e-11 2.919e-09
98 REGULATION OF HEMOPOIESIS 60 314 8.439e-11 4.007e-09
99 TAXIS 78 464 9.679e-11 4.507e-09
100 TUBE MORPHOGENESIS 61 323 9.687e-11 4.507e-09
101 REGULATION OF MAPK CASCADE 100 660 1.081e-10 4.982e-09
102 NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 108 740 1.824e-10 8.241e-09
103 CENTRAL NERVOUS SYSTEM DEVELOPMENT 122 872 1.81e-10 8.241e-09
104 REGULATION OF DEVELOPMENTAL GROWTH 56 289 2.064e-10 9.233e-09
105 POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 74 437 2.089e-10 9.257e-09
106 CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND 114 799 2.26e-10 9.92e-09
107 RESPONSE TO OXYGEN CONTAINING COMPOUND 173 1381 2.377e-10 1.034e-08
108 MUSCLE TISSUE DEVELOPMENT 54 275 2.6e-10 1.12e-08
109 HEAD DEVELOPMENT 104 709 3.007e-10 1.284e-08
110 LEUKOCYTE DIFFERENTIATION 56 292 3.104e-10 1.313e-08
111 REGULATION OF EPITHELIAL CELL MIGRATION 39 166 3.763e-10 1.577e-08
112 LYMPHOCYTE ACTIVATION 62 342 3.856e-10 1.602e-08
113 REGULATION OF LEUKOCYTE DIFFERENTIATION 48 232 4.084e-10 1.682e-08
114 LEUKOCYTE CELL CELL ADHESION 51 255 4.145e-10 1.692e-08
115 POSITIVE REGULATION OF MAPK CASCADE 77 470 4.41e-10 1.784e-08
116 MORPHOGENESIS OF A BRANCHING STRUCTURE 39 167 4.543e-10 1.822e-08
117 POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS 120 867 5.048e-10 2.008e-08
118 REGULATION OF GROWTH 95 633 5.372e-10 2.118e-08
119 REGULATION OF AXONOGENESIS 39 168 5.476e-10 2.141e-08
120 ENDOTHELIUM DEVELOPMENT 27 90 6.073e-10 2.335e-08
121 STEM CELL DIFFERENTIATION 42 190 6.064e-10 2.335e-08
122 CELL PROLIFERATION 99 672 6.438e-10 2.456e-08
123 POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 38 162 6.616e-10 2.503e-08
124 REGULATION OF CELL CELL ADHESION 66 380 6.797e-10 2.55e-08
125 LEUKOCYTE ACTIVATION 70 414 6.903e-10 2.57e-08
126 NEGATIVE REGULATION OF GROWTH 48 236 7.486e-10 2.764e-08
127 SENSORY ORGAN DEVELOPMENT 79 493 7.596e-10 2.783e-08
128 REGULATION OF HOMOTYPIC CELL CELL ADHESION 57 307 7.781e-10 2.829e-08
129 MUSCLE CELL DIFFERENTIATION 48 237 8.686e-10 3.133e-08
130 CELL SUBSTRATE ADHESION 38 164 9.618e-10 3.443e-08
131 SKELETAL SYSTEM DEVELOPMENT 74 455 1.348e-09 4.789e-08
132 REGULATION OF KINASE ACTIVITY 109 776 1.412e-09 4.978e-08
133 CELL PROJECTION ORGANIZATION 122 902 1.505e-09 5.264e-08
134 CYTOSKELETON ORGANIZATION 115 838 1.955e-09 6.789e-08
135 NEURON PROJECTION GUIDANCE 43 205 2.123e-09 7.318e-08
136 REGULATION OF ENDOTHELIAL CELL MIGRATION 30 114 2.288e-09 7.827e-08
137 NEGATIVE REGULATION OF CELL DEATH 118 872 2.752e-09 9.348e-08
138 CELL DEATH 131 1001 3.009e-09 1.015e-07
139 POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 146 1152 3.175e-09 1.063e-07
140 POSITIVE REGULATION OF TRANSPORT 124 936 3.916e-09 1.301e-07
141 REGULATION OF CELL ACTIVATION 76 484 4.025e-09 1.319e-07
142 REGULATION OF CELL SIZE 38 172 4.003e-09 1.319e-07
143 REGULATION OF GTPASE ACTIVITY 96 673 6.364e-09 2.071e-07
144 REGULATION OF ANATOMICAL STRUCTURE SIZE 74 472 6.908e-09 2.232e-07
145 POSITIVE REGULATION OF LOCOMOTION 68 420 7.588e-09 2.435e-07
146 RESPONSE TO ORGANIC CYCLIC COMPOUND 121 917 7.716e-09 2.459e-07
147 RESPONSE TO LIPID 118 888 7.973e-09 2.524e-07
148 REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 51 278 9.15e-09 2.877e-07
149 RESPONSE TO OXYGEN LEVELS 55 311 9.325e-09 2.912e-07
150 REGULATION OF EXTENT OF CELL GROWTH 27 101 9.911e-09 3.074e-07
151 WOUND HEALING 73 470 1.306e-08 4.024e-07
152 RESPONSE TO MECHANICAL STIMULUS 42 210 1.425e-08 4.361e-07
153 NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH 24 84 1.575e-08 4.789e-07
154 NEGATIVE REGULATION OF GENE EXPRESSION 176 1493 1.676e-08 5.064e-07
155 POSITIVE REGULATION OF CELL CELL ADHESION 46 243 1.787e-08 5.366e-07
156 DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS 27 104 1.959e-08 5.807e-07
157 BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE 31 131 1.948e-08 5.807e-07
158 CELLULAR RESPONSE TO LIPID 71 457 2.042e-08 6.013e-07
159 SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 59 352 2.087e-08 6.107e-07
160 ACTIN FILAMENT BASED PROCESS 70 450 2.439e-08 7.05e-07
161 POSITIVE REGULATION OF CELL ACTIVATION 54 311 2.428e-08 7.05e-07
162 NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 48 262 2.594e-08 7.45e-07
163 SEMAPHORIN PLEXIN SIGNALING PATHWAY 15 36 2.79e-08 7.966e-07
164 NEGATIVE REGULATION OF CELL GROWTH 36 170 3.278e-08 9.3e-07
165 DEVELOPMENTAL GROWTH 56 333 4.227e-08 1.192e-06
166 REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION 27 108 4.642e-08 1.301e-06
167 REGULATION OF CHEMOTAXIS 37 180 4.832e-08 1.346e-06
168 OSSIFICATION 46 251 4.983e-08 1.372e-06
169 CELL CYCLE 157 1316 4.958e-08 1.372e-06
170 NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS 176 1517 5.214e-08 1.427e-06
171 NEGATIVE REGULATION OF CELL CYCLE 67 433 5.978e-08 1.627e-06
172 POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION 52 303 6.505e-08 1.76e-06
173 RENAL TUBULE DEVELOPMENT 22 78 8.004e-08 2.153e-06
174 ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY 94 689 8.099e-08 2.166e-06
175 REGULATION OF TRANSFERASE ACTIVITY 120 946 8.312e-08 2.21e-06
176 FOREBRAIN DEVELOPMENT 58 357 8.442e-08 2.23e-06
177 GROWTH 64 410 8.485e-08 2.23e-06
178 KIDNEY EPITHELIUM DEVELOPMENT 29 125 8.799e-08 2.3e-06
179 REGULATION OF IMMUNE RESPONSE 111 858 9.402e-08 2.444e-06
180 REGULATION OF CELLULAR LOCALIZATION 152 1277 9.537e-08 2.465e-06
181 POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT 43 232 9.683e-08 2.489e-06
182 REGULATION OF CELL CYCLE 120 949 9.888e-08 2.528e-06
183 SKELETAL SYSTEM MORPHOGENESIS 39 201 1.082e-07 2.751e-06
184 LYMPHOCYTE DIFFERENTIATION 40 209 1.1e-07 2.766e-06
185 REGULATION OF VASCULATURE DEVELOPMENT 43 233 1.099e-07 2.766e-06
186 TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 97 724 1.206e-07 3.018e-06
187 NEPHRON EPITHELIUM DEVELOPMENT 24 93 1.342e-07 3.34e-06
188 MUSCLE ORGAN DEVELOPMENT 48 277 1.529e-07 3.785e-06
189 HEART MORPHOGENESIS 40 212 1.638e-07 4.033e-06
190 REGULATION OF TYPE 2 IMMUNE RESPONSE 12 26 1.769e-07 4.332e-06
191 NEURAL CREST CELL DIFFERENTIATION 21 75 1.802e-07 4.391e-06
192 RESPONSE TO NITROGEN COMPOUND 110 859 1.819e-07 4.409e-06
193 REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 42 229 1.838e-07 4.432e-06
194 NEPHRON DEVELOPMENT 27 115 1.872e-07 4.49e-06
195 REGULATION OF CARTILAGE DEVELOPMENT 19 63 1.903e-07 4.542e-06
196 NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION 31 144 1.962e-07 4.657e-06
197 REGULATION OF MYELOID CELL DIFFERENTIATION 36 183 2.313e-07 5.436e-06
198 EXTRACELLULAR MATRIX DISASSEMBLY 21 76 2.308e-07 5.436e-06
199 NEGATIVE REGULATION OF NEURON DIFFERENTIATION 37 191 2.372e-07 5.518e-06
200 RESPONSE TO REACTIVE OXYGEN SPECIES 37 191 2.372e-07 5.518e-06
201 APPENDAGE DEVELOPMENT 34 169 2.855e-07 6.577e-06
202 LIMB DEVELOPMENT 34 169 2.855e-07 6.577e-06
203 CELL CYCLE PROCESS 131 1081 2.903e-07 6.653e-06
204 CARTILAGE DEVELOPMENT 31 147 3.187e-07 7.269e-06
205 REGULATION OF PROTEIN LOCALIZATION 118 950 3.272e-07 7.427e-06
206 CELL PART MORPHOGENESIS 86 633 3.48e-07 7.859e-06
207 CONNECTIVE TISSUE DEVELOPMENT 37 194 3.563e-07 8.009e-06
208 POSITIVE REGULATION OF KINASE ACTIVITY 70 482 3.702e-07 8.283e-06
209 LYMPHOCYTE COSTIMULATION 21 78 3.729e-07 8.303e-06
210 IN UTERO EMBRYONIC DEVELOPMENT 51 311 3.747e-07 8.303e-06
211 REGULATION OF CELL GROWTH 60 391 3.891e-07 8.581e-06
212 NEGATIVE REGULATION OF CELL DEVELOPMENT 50 303 4.005e-07 8.79e-06
213 ENDOTHELIAL CELL DIFFERENTIATION 20 72 4.055e-07 8.857e-06
214 PROTEIN PHOSPHORYLATION 117 944 4.115e-07 8.948e-06
215 RESPONSE TO MOLECULE OF BACTERIAL ORIGIN 52 321 4.269e-07 9.238e-06
216 CHONDROCYTE DIFFERENTIATION 18 60 4.347e-07 9.365e-06
217 TELENCEPHALON DEVELOPMENT 41 228 4.424e-07 9.486e-06
218 EPITHELIAL CELL DIFFERENTIATION 71 495 4.929e-07 1.052e-05
219 NEGATIVE REGULATION OF AXON EXTENSION 14 38 5.016e-07 1.066e-05
220 STRIATED MUSCLE CELL DIFFERENTIATION 34 173 5.077e-07 1.074e-05
221 REGULATION OF SECRETION 92 699 5.692e-07 1.198e-05
222 NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 26 115 6.873e-07 1.44e-05
223 EYE DEVELOPMENT 52 326 6.948e-07 1.45e-05
224 RESPONSE TO HORMONE 111 893 7.142e-07 1.484e-05
225 SYNAPSE ORGANIZATION 30 145 7.546e-07 1.561e-05
226 EMBRYONIC MORPHOGENESIS 75 539 7.826e-07 1.604e-05
227 HEART VALVE DEVELOPMENT 13 34 7.807e-07 1.604e-05
228 T CELL DIFFERENTIATION 27 123 7.874e-07 1.607e-05
229 REGULATION OF CELLULAR COMPONENT SIZE 53 337 8.521e-07 1.731e-05
230 SPROUTING ANGIOGENESIS 15 45 8.795e-07 1.772e-05
231 ENDOCHONDRAL BONE MORPHOGENESIS 15 45 8.795e-07 1.772e-05
232 POSITIVE REGULATION OF AXONOGENESIS 19 69 9.112e-07 1.827e-05
233 AMEBOIDAL TYPE CELL MIGRATION 31 154 9.296e-07 1.856e-05
234 CELL CELL SIGNALING 98 767 9.551e-07 1.899e-05
235 REGULATION OF OSSIFICATION 34 178 1.01e-06 2.001e-05
236 POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION 24 103 1.023e-06 2.018e-05
237 CARDIAC MUSCLE TISSUE DEVELOPMENT 29 140 1.118e-06 2.195e-05
238 REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 67 470 1.284e-06 2.511e-05
239 CELL MATRIX ADHESION 26 119 1.376e-06 2.679e-05
240 REGULATION OF ERK1 AND ERK2 CASCADE 41 238 1.409e-06 2.732e-05
241 RESPIRATORY SYSTEM DEVELOPMENT 36 197 1.477e-06 2.852e-05
242 REGULATION OF CELL SUBSTRATE ADHESION 33 173 1.496e-06 2.864e-05
243 NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION 23 98 1.494e-06 2.864e-05
244 NEGATIVE REGULATION OF AXONOGENESIS 18 65 1.604e-06 3.059e-05
245 REGULATION OF T HELPER CELL DIFFERENTIATION 11 26 1.701e-06 3.23e-05
246 POSITIVE REGULATION OF CELL CYCLE ARREST 21 85 1.74e-06 3.291e-05
247 CELLULAR RESPONSE TO OXYGEN LEVELS 29 143 1.762e-06 3.32e-05
248 LEUKOCYTE MIGRATION 43 259 2.16e-06 4.053e-05
249 REGULATION OF INTERLEUKIN 2 PRODUCTION 15 48 2.227e-06 4.162e-05
250 REGULATION OF RESPONSE TO EXTERNAL STIMULUS 112 926 2.392e-06 4.452e-05
251 HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES 30 153 2.451e-06 4.543e-05
252 CELL JUNCTION ORGANIZATION 34 185 2.507e-06 4.611e-05
253 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY 69 498 2.502e-06 4.611e-05
254 REGULATION OF NEURON DEATH 42 252 2.551e-06 4.673e-05
255 TISSUE REMODELING 21 87 2.607e-06 4.757e-05
256 POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE 8 14 2.742e-06 4.964e-05
257 NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION 29 146 2.735e-06 4.964e-05
258 POSITIVE REGULATION OF CELL CYCLE 51 332 2.756e-06 4.971e-05
259 POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION 9 18 2.773e-06 4.981e-05
260 POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION 27 131 2.865e-06 5.112e-05
261 MITOTIC CELL CYCLE 96 766 2.867e-06 5.112e-05
262 REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION 24 109 2.998e-06 5.324e-05
263 ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY 35 195 3.142e-06 5.558e-05
264 POSITIVE REGULATION OF SECRETION 55 370 3.18e-06 5.606e-05
265 RESPONSE TO OXIDATIVE STRESS 53 352 3.253e-06 5.712e-05
266 POSITIVE REGULATION OF HEMOPOIESIS 31 163 3.28e-06 5.716e-05
267 REGULATION OF CELL JUNCTION ASSEMBLY 18 68 3.271e-06 5.716e-05
268 NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 25 117 3.346e-06 5.787e-05
269 REGULATION OF LYMPHOCYTE DIFFERENTIATION 27 132 3.337e-06 5.787e-05
270 REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION 13 38 3.384e-06 5.832e-05
271 PATTERN SPECIFICATION PROCESS 60 418 3.642e-06 6.252e-05
272 BONE DEVELOPMENT 30 156 3.712e-06 6.35e-05
273 KIDNEY MORPHOGENESIS 20 82 3.778e-06 6.439e-05
274 EPITHELIAL TO MESENCHYMAL TRANSITION 16 56 3.857e-06 6.55e-05
275 REGULATION OF LEUKOCYTE PROLIFERATION 36 206 4.321e-06 7.31e-05
276 REGULATION OF T HELPER 2 CELL DIFFERENTIATION 7 11 4.473e-06 7.542e-05
277 REGULATION OF AXON GUIDANCE 13 39 4.713e-06 7.889e-05
278 NEGATIVE CHEMOTAXIS 13 39 4.713e-06 7.889e-05
279 PROTEIN COMPLEX SUBUNIT ORGANIZATION 167 1527 4.762e-06 7.943e-05
280 ACTIN FILAMENT ORGANIZATION 32 174 4.823e-06 8.014e-05
281 REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 36 207 4.842e-06 8.018e-05
282 CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION 31 166 4.864e-06 8.025e-05
283 SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 26 127 4.95e-06 8.115e-05
284 REGULATION OF OSTEOBLAST DIFFERENTIATION 24 112 4.953e-06 8.115e-05
285 ARTERY MORPHOGENESIS 15 51 5.19e-06 8.443e-05
286 NEGATIVE REGULATION OF CHEMOTAXIS 15 51 5.19e-06 8.443e-05
287 IMMUNE RESPONSE 127 1100 5.47e-06 8.85e-05
288 REGULATION OF ENDOTHELIAL CELL PROLIFERATION 22 98 5.478e-06 8.85e-05
289 POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION 27 136 6.021e-06 9.661e-05
290 CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION 10 24 6.015e-06 9.661e-05
291 REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION 33 184 6.044e-06 9.664e-05
292 EMBRYONIC ORGAN DEVELOPMENT 58 406 6.105e-06 9.728e-05
293 CELL FATE COMMITMENT 38 227 6.773e-06 0.0001076
294 REGULATION OF CHONDROCYTE DIFFERENTIATION 14 46 6.851e-06 0.0001081
295 REGULATION OF ALPHA BETA T CELL DIFFERENTIATION 14 46 6.851e-06 0.0001081
296 DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION 78 602 7.379e-06 0.000116
297 EPITHELIAL CELL DEVELOPMENT 33 186 7.669e-06 0.0001201
298 T CELL RECEPTOR SIGNALING PATHWAY 28 146 8.157e-06 0.0001274
299 EAR DEVELOPMENT 34 195 8.299e-06 0.0001292
300 MUCOPOLYSACCHARIDE METABOLIC PROCESS 23 108 8.636e-06 0.0001339
301 CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES 35 204 8.879e-06 0.0001372
302 REGULATION OF CELLULAR COMPONENT BIOGENESIS 94 767 9.176e-06 0.0001414
303 CELLULAR RESPONSE TO BIOTIC STIMULUS 30 163 9.285e-06 0.0001421
304 REGULATION OF RESPONSE TO STRESS 160 1468 9.266e-06 0.0001421
305 POSITIVE REGULATION OF TRANSFERASE ACTIVITY 79 616 9.424e-06 0.0001438
306 REGULATION OF MAP KINASE ACTIVITY 48 319 9.469e-06 0.000144
307 MYELOID CELL DIFFERENTIATION 33 189 1.087e-05 0.0001647
308 T CELL SELECTION 12 36 1.095e-05 0.0001654
309 POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION 17 67 1.13e-05 0.0001701
310 REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY 38 232 1.137e-05 0.0001706
311 POSITIVE REGULATION OF VASCULATURE DEVELOPMENT 26 133 1.188e-05 0.0001771
312 CARDIAC MUSCLE CELL DIFFERENTIATION 18 74 1.187e-05 0.0001771
313 POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION 11 31 1.291e-05 0.000192
314 NEGATIVE REGULATION OF MITOTIC CELL CYCLE 34 199 1.299e-05 0.0001925
315 CELLULAR RESPONSE TO HORMONE STIMULUS 72 552 1.309e-05 0.0001934
316 REGULATION OF ION TRANSPORT 76 592 1.337e-05 0.0001969
317 CHONDROCYTE DEVELOPMENT 9 21 1.35e-05 0.0001981
318 CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND 63 465 1.387e-05 0.0002029
319 REGULATION OF ALPHA BETA T CELL ACTIVATION 17 68 1.397e-05 0.0002038
320 REGULATION OF CYTOKINE PRODUCTION 73 563 1.402e-05 0.0002039
321 EPITHELIAL CELL PROLIFERATION 20 89 1.42e-05 0.0002059
322 ARTERY DEVELOPMENT 18 75 1.448e-05 0.0002093
323 NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION 19 82 1.453e-05 0.0002093
324 REGULATION OF NEURON APOPTOTIC PROCESS 33 192 1.525e-05 0.0002189
325 RESPONSE TO ALCOHOL 52 362 1.555e-05 0.0002226
326 RAS PROTEIN SIGNAL TRANSDUCTION 27 143 1.58e-05 0.0002256
327 CARDIAC VENTRICLE MORPHOGENESIS 16 62 1.614e-05 0.0002297
328 REGULATION OF GLIOGENESIS 20 90 1.693e-05 0.0002394
329 MESONEPHROS DEVELOPMENT 20 90 1.693e-05 0.0002394
330 REGULATION OF SYSTEM PROCESS 67 507 1.701e-05 0.0002398
331 REGULATION OF HORMONE LEVELS 64 478 1.731e-05 0.0002433
332 ENDOCARDIAL CUSHION DEVELOPMENT 11 32 1.829e-05 0.0002563
333 CELL CYCLE CHECKPOINT 33 194 1.9e-05 0.0002655
334 POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION 10 27 2.08e-05 0.0002889
335 NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION 13 44 2.08e-05 0.0002889
336 TISSUE MIGRATION 19 84 2.094e-05 0.00029
337 CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT 17 70 2.107e-05 0.0002909
338 DEVELOPMENTAL CELL GROWTH 18 77 2.131e-05 0.0002925
339 AORTA MORPHOGENESIS 9 22 2.125e-05 0.0002925
340 GLAND DEVELOPMENT 55 395 2.214e-05 0.0003029
341 POSITIVE REGULATION OF CELL SUBSTRATE ADHESION 21 99 2.233e-05 0.0003047
342 REGULATION OF EPITHELIAL CELL DIFFERENTIATION 24 122 2.276e-05 0.0003096
343 MULTI MULTICELLULAR ORGANISM PROCESS 35 213 2.313e-05 0.0003138
344 DNA INTEGRITY CHECKPOINT 27 146 2.332e-05 0.0003154
345 RESPONSE TO VITAMIN D 11 33 2.55e-05 0.0003439
346 NEGATIVE REGULATION OF CELL CYCLE PROCESS 35 214 2.561e-05 0.0003444
347 POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE 30 172 2.738e-05 0.0003671
348 MULTICELLULAR ORGANISM REPRODUCTION 92 768 2.779e-05 0.0003716
349 REGULATION OF CELL CYCLE ARREST 22 108 2.804e-05 0.0003738
350 CELLULAR RESPONSE TO STRESS 166 1565 2.841e-05 0.0003777
351 REGULATION OF PROTEIN SECRETION 54 389 2.852e-05 0.0003781
352 MULTICELLULAR ORGANISMAL MACROMOLECULE METABOLIC PROCESS 18 79 3.086e-05 0.0004068
353 BONE MORPHOGENESIS 18 79 3.086e-05 0.0004068
354 REGULATION OF MITOTIC CELL CYCLE 62 468 3.216e-05 0.0004227
355 GLYCOPROTEIN METABOLIC PROCESS 50 353 3.274e-05 0.0004292
356 ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II 20 94 3.316e-05 0.0004322
357 ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS II 20 94 3.316e-05 0.0004322
358 RESPONSE TO NUTRIENT 32 191 3.443e-05 0.0004474
359 VASCULOGENESIS 15 59 3.573e-05 0.0004631
360 REGULATION OF HORMONE SECRETION 40 262 3.639e-05 0.0004704
361 REPRODUCTION 141 1297 3.673e-05 0.0004735
362 POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION 7 14 3.767e-05 0.0004825
363 G1 DNA DAMAGE CHECKPOINT 17 73 3.775e-05 0.0004825
364 REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION 17 73 3.775e-05 0.0004825
365 PLATELET ACTIVATION 26 142 3.916e-05 0.0004992
366 NEURON PROJECTION EXTENSION 14 53 4.08e-05 0.0005159
367 MESONEPHRIC TUBULE MORPHOGENESIS 14 53 4.08e-05 0.0005159
368 SKELETAL MUSCLE CELL DIFFERENTIATION 14 53 4.08e-05 0.0005159
369 CELL CYCLE G1 S PHASE TRANSITION 22 111 4.362e-05 0.0005486
370 G1 S TRANSITION OF MITOTIC CELL CYCLE 22 111 4.362e-05 0.0005486
371 METANEPHROS DEVELOPMENT 18 81 4.405e-05 0.0005525
372 CARDIOCYTE DIFFERENTIATION 20 96 4.562e-05 0.0005706
373 INFLAMMATORY RESPONSE 60 454 4.598e-05 0.0005736
374 NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 41 274 4.686e-05 0.000583
375 REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS 8 19 4.831e-05 0.0005994
376 PHOSPHORYLATION 134 1228 4.847e-05 0.0005998
377 CARDIAC CHAMBER DEVELOPMENT 26 144 5.015e-05 0.0006189
378 CELLULAR RESPONSE TO NITROGEN COMPOUND 65 505 5.107e-05 0.0006287
379 NEGATIVE REGULATION OF HEMOPOIESIS 24 128 5.154e-05 0.0006328
380 BEHAVIOR 66 516 5.437e-05 0.0006658
381 PALLIUM DEVELOPMENT 27 153 5.485e-05 0.0006698
382 REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 34 213 5.509e-05 0.000671
383 CEREBRAL CORTEX DEVELOPMENT 21 105 5.615e-05 0.0006822
384 RESPONSE TO STEROID HORMONE 64 497 5.736e-05 0.0006951
385 REGULATION OF SYNAPSE ORGANIZATION 22 113 5.793e-05 0.0007001
386 SMOOTH MUSCLE CELL DIFFERENTIATION 10 30 5.958e-05 0.0007182
387 RESPONSE TO BACTERIUM 67 528 6.117e-05 0.0007355
388 POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 27 154 6.162e-05 0.0007371
389 NEGATIVE REGULATION OF CELL ADHESION 35 223 6.15e-05 0.0007371
390 PROTEOGLYCAN METABOLIC PROCESS 18 83 6.202e-05 0.0007399
391 NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS 51 372 6.52e-05 0.0007759
392 REGULATION OF HEAT GENERATION 7 15 6.585e-05 0.0007797
393 RESPONSE TO MURAMYL DIPEPTIDE 7 15 6.585e-05 0.0007797
394 ADAPTIVE IMMUNE RESPONSE 42 288 6.965e-05 0.0008225
395 MEMBRANE ASSEMBLY 9 25 7.034e-05 0.0008286
396 ACTIVATION OF PROTEIN KINASE ACTIVITY 41 279 7.102e-05 0.0008344
397 REGULATION OF CELL CYCLE G1 S PHASE TRANSITION 26 147 7.187e-05 0.0008423
398 REGULATION OF SMOOTH MUSCLE CELL MIGRATION 13 49 7.27e-05 0.0008478
399 CARDIAC CELL DEVELOPMENT 13 49 7.27e-05 0.0008478
400 CYTOKINESIS 18 84 7.322e-05 0.0008517
401 AMINOGLYCAN BIOSYNTHETIC PROCESS 21 107 7.49e-05 0.0008658
402 REGULATION OF T CELL DIFFERENTIATION 21 107 7.49e-05 0.0008658
403 LYMPH VESSEL DEVELOPMENT 8 20 7.499e-05 0.0008658
404 APOPTOTIC SIGNALING PATHWAY 42 289 7.545e-05 0.0008689
405 REGULATION OF DENDRITIC SPINE DEVELOPMENT 14 56 7.887e-05 0.0009061
406 RESPONSE TO PEPTIDE 54 404 8.009e-05 0.0009164
407 CEREBRAL CORTEX CELL MIGRATION 12 43 8.016e-05 0.0009164
408 INTERFERON GAMMA MEDIATED SIGNALING PATHWAY 16 70 8.053e-05 0.0009184
409 REGULATION OF OSTEOCLAST DIFFERENTIATION 15 63 8.121e-05 0.0009239
410 REGULATION OF INTERLEUKIN 4 PRODUCTION 10 31 8.18e-05 0.0009283
411 CIRCULATORY SYSTEM PROCESS 50 366 8.376e-05 0.0009428
412 MITOTIC DNA INTEGRITY CHECKPOINT 20 100 8.364e-05 0.0009428
413 GLIAL CELL MIGRATION 11 37 8.409e-05 0.0009428
414 POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION 11 37 8.409e-05 0.0009428
415 AXON EXTENSION 11 37 8.409e-05 0.0009428
416 REGULATION OF PEPTIDE SECRETION 33 209 8.744e-05 0.000978
417 REGULATION OF ADHERENS JUNCTION ORGANIZATION 13 50 9.126e-05 0.001018
418 SOMITE DEVELOPMENT 17 78 9.21e-05 0.001025
419 CELL CYCLE PHASE TRANSITION 38 255 9.534e-05 0.001059
420 HEMOSTASIS 44 311 9.741e-05 0.001079
421 NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT 9 26 0.0001001 0.001107
422 PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS 199 1977 0.0001023 0.001128
423 REPRODUCTIVE SYSTEM DEVELOPMENT 54 408 0.000104 0.001143
424 POSITIVE REGULATION OF CELL CYCLE PROCESS 37 247 0.000105 0.001152
425 REGULATION OF CELL CYCLE PROCESS 69 558 0.0001063 0.001163
426 DENDRITE DEVELOPMENT 17 79 0.0001089 0.001189
427 NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION 7 16 0.0001091 0.001189
428 PATTERNING OF BLOOD VESSELS 10 32 0.0001107 0.0012
429 NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 10 32 0.0001107 0.0012
430 NEURAL CREST CELL MIGRATION 13 51 0.0001138 0.001228
431 REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 13 51 0.0001138 0.001228
432 REGULATION OF BLOOD CIRCULATION 42 295 0.0001205 0.001297
433 CELL DIVISION 59 460 0.0001228 0.001319
434 NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS 24 135 0.0001235 0.001324
435 REGULATION OF MUSCLE TISSUE DEVELOPMENT 20 103 0.0001284 0.001367
436 POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION 17 80 0.0001283 0.001367
437 REGULATION OF MUSCLE ORGAN DEVELOPMENT 20 103 0.0001284 0.001367
438 POSITIVE REGULATION OF HORMONE SECRETION 22 119 0.0001292 0.001372
439 RESPONSE TO TRANSFORMING GROWTH FACTOR BETA 25 144 0.0001335 0.001415
440 PROTEIN LOCALIZATION 183 1805 0.0001365 0.001443
441 REGULATION OF STEM CELL PROLIFERATION 18 88 0.0001379 0.001455
442 POSITIVE REGULATION OF IMMUNE RESPONSE 69 563 0.000139 0.001463
443 NEGATIVE REGULATION OF AXON GUIDANCE 9 27 0.0001398 0.001465
444 CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS 9 27 0.0001398 0.001465
445 NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS 6 12 0.0001405 0.00147
446 CYTOSKELETON DEPENDENT CYTOKINESIS 11 39 0.0001425 0.001486
447 SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE 19 96 0.0001442 0.001501
448 REGULATION OF DENDRITE DEVELOPMENT 22 120 0.0001467 0.001523
449 NEURON RECOGNITION 10 33 0.0001477 0.001527
450 EMBRYONIC EYE MORPHOGENESIS 10 33 0.0001477 0.001527
451 EMBRYONIC ORGAN MORPHOGENESIS 40 279 0.0001487 0.001534
452 RESPONSE TO IONIZING RADIATION 25 145 0.0001495 0.001539
453 NEGATIVE REGULATION OF NEURON DEATH 28 171 0.0001551 0.001593
454 SKELETAL MUSCLE ORGAN DEVELOPMENT 24 137 0.0001562 0.001601
455 PEPTIDYL THREONINE MODIFICATION 12 46 0.0001632 0.001669
456 CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS 8 22 0.0001652 0.001682
457 POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION 8 22 0.0001652 0.001682
458 GLAND MORPHOGENESIS 19 97 0.0001663 0.001686
459 NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 22 121 0.0001662 0.001686
460 REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 15 67 0.0001708 0.001728
461 REGULATION OF BODY FLUID LEVELS 63 506 0.0001721 0.001737
462 MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY 14 60 0.0001753 0.001765
463 FORELIMB MORPHOGENESIS 11 40 0.0001827 0.001836
464 REGULATION OF CELL MATRIX ADHESION 18 90 0.000186 0.001866
465 EMBRYONIC SKELETAL SYSTEM DEVELOPMENT 22 122 0.000188 0.001877
466 LOCALIZATION WITHIN MEMBRANE 22 122 0.000188 0.001877
467 NOTCH SIGNALING PATHWAY 21 114 0.0001918 0.001898
468 RESPONSE TO VITAMIN 19 98 0.0001914 0.001898
469 REGULATION OF SPROUTING ANGIOGENESIS 9 28 0.0001918 0.001898
470 POSITIVE REGULATION OF PHOSPHATASE ACTIVITY 9 28 0.0001918 0.001898
471 CARDIAC VENTRICLE DEVELOPMENT 20 106 0.0001931 0.001908
472 REGIONALIZATION 43 311 0.0001952 0.001925
473 NEGATIVE REGULATION OF TRANSPORT 58 458 0.0001962 0.001926
474 POSITIVE REGULATION OF DEVELOPMENTAL GROWTH 26 156 0.0001962 0.001926
475 NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 80 684 0.0001996 0.001955
476 NERVE DEVELOPMENT 15 68 0.0002034 0.001982
477 POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 15 68 0.0002034 0.001982
478 POSITIVE REGULATION OF GLIOGENESIS 12 47 0.0002036 0.001982
479 REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 19 99 0.0002197 0.00213
480 REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 19 99 0.0002197 0.00213
481 AMINOGLYCAN METABOLIC PROCESS 27 166 0.0002255 0.002182
482 IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY 44 323 0.0002315 0.002235
483 AORTA DEVELOPMENT 11 41 0.0002322 0.002237
484 INNERVATION 8 23 0.0002359 0.002268
485 MICROTUBULE ORGANIZING CENTER ORGANIZATION 17 84 0.0002395 0.002293
486 NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION 17 84 0.0002395 0.002293
487 NEGATIVE REGULATION OF CELL ACTIVATION 26 158 0.0002418 0.002305
488 SYNAPSE ASSEMBLY 15 69 0.0002414 0.002305
489 REGULATION OF ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN 6 13 0.0002437 0.002309
490 SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE 6 13 0.0002437 0.002309
491 POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION 6 13 0.0002437 0.002309
492 NEGATIVE REGULATION OF PHOSPHORYLATION 54 422 0.0002474 0.00234
493 SENSORY ORGAN MORPHOGENESIS 35 239 0.0002486 0.002346
494 REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 12 48 0.0002524 0.002377
495 FOREBRAIN CELL MIGRATION 14 62 0.0002534 0.002378
496 NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS 117 1087 0.0002535 0.002378
497 CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION 9 29 0.0002588 0.002423
498 RETINAL GANGLION CELL AXON GUIDANCE 7 18 0.000264 0.002457
499 PERICARDIUM DEVELOPMENT 7 18 0.000264 0.002457
500 PHARYNGEAL SYSTEM DEVELOPMENT 7 18 0.000264 0.002457
501 LEUKOCYTE CHEMOTAXIS 21 117 0.0002785 0.002586
502 ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN 28 177 0.0002805 0.0026
503 ANTIGEN PROCESSING AND PRESENTATION 32 213 0.0002823 0.002612
504 EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS 18 93 0.0002856 0.002631
505 MULTICELLULAR ORGANISM METABOLIC PROCESS 18 93 0.0002856 0.002631
506 INTERACTION WITH HOST 23 134 0.0002888 0.002656
507 DENDRITE MORPHOGENESIS 11 42 0.0002925 0.002674
508 POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION 11 42 0.0002925 0.002674
509 REGULATION OF HEART GROWTH 11 42 0.0002925 0.002674
510 OSTEOBLAST DIFFERENTIATION 22 126 0.0003025 0.00276
511 REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY 12 49 0.0003106 0.002828
512 RESPONSE TO BIOTIC STIMULUS 98 886 0.0003137 0.002851
513 REGULATION OF ORGAN MORPHOGENESIS 35 242 0.0003163 0.002869
514 NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 10 36 0.0003266 0.002922
515 CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT 10 36 0.0003266 0.002922
516 POSITIVE REGULATION OF AXON EXTENSION 10 36 0.0003266 0.002922
517 OLFACTORY LOBE DEVELOPMENT 10 36 0.0003266 0.002922
518 NEGATIVE REGULATION OF MUSCLE ORGAN DEVELOPMENT 10 36 0.0003266 0.002922
519 NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT 10 36 0.0003266 0.002922
520 CELL GROWTH 23 135 0.0003228 0.002922
521 ENDOTHELIAL CELL PROLIFERATION 8 24 0.0003297 0.002944
522 CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM 36 252 0.0003332 0.00297
523 ADHERENS JUNCTION ORGANIZATION 15 71 0.0003358 0.002987
524 MICROTUBULE CYTOSKELETON ORGANIZATION 46 348 0.0003365 0.002988
525 MEMBRANE BIOGENESIS 9 30 0.0003442 0.003033
526 CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS 9 30 0.0003442 0.003033
527 OSTEOCLAST DIFFERENTIATION 9 30 0.0003442 0.003033
528 CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS 9 30 0.0003442 0.003033
529 CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS 11 43 0.0003655 0.003215
530 ENDOTHELIAL CELL MIGRATION 13 57 0.000376 0.003301
531 MUSCLE CELL DEVELOPMENT 22 128 0.00038 0.003329
532 CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS 7 19 0.0003898 0.003405
533 POSITIVE REGULATION OF CYTOKINE PRODUCTION 48 370 0.00039 0.003405
534 REGULATION OF CATABOLIC PROCESS 83 731 0.0003965 0.003455
535 VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY 6 14 0.0003982 0.003463
536 REGULATION OF ACTIN FILAMENT BASED PROCESS 42 312 0.0004081 0.003543
537 CELLULAR RESPONSE TO MECHANICAL STIMULUS 16 80 0.0004156 0.003601
538 CARDIAC CHAMBER MORPHOGENESIS 19 104 0.0004233 0.003648
539 RESPONSE TO CAMP 19 104 0.0004233 0.003648
540 CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES 19 104 0.0004233 0.003648
541 TUBE FORMATION 22 129 0.0004248 0.003653
542 NEGATIVE REGULATION OF SECRETION 30 200 0.0004423 0.003797
543 MITOTIC CYTOKINESIS 9 31 0.0004516 0.003842
544 REGULATION OF PEPTIDE TRANSPORT 36 256 0.0004513 0.003842
545 POSTSYNAPTIC MEMBRANE ORGANIZATION 8 25 0.0004517 0.003842
546 CHONDROITIN SULFATE BIOSYNTHETIC PROCESS 8 25 0.0004517 0.003842
547 MATERNAL PLACENTA DEVELOPMENT 9 31 0.0004516 0.003842
548 REGULATION OF ORGAN GROWTH 15 73 0.0004603 0.003908
549 POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION 12 51 0.0004618 0.003914
550 POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS 25 156 0.0004756 0.004019
551 RESPONSE TO CYTOKINE 81 714 0.0004759 0.004019
552 PROTEIN AUTOPHOSPHORYLATION 29 192 0.0004864 0.0041
553 SEGMENTATION 17 89 0.0004893 0.004117
554 MITOTIC CELL CYCLE CHECKPOINT 23 139 0.0004962 0.00416
555 REGULATION OF CELL SHAPE 23 139 0.0004962 0.00416
556 SINGLE ORGANISM BEHAVIOR 49 384 0.0004989 0.004175
557 DEVELOPMENTAL MATURATION 29 193 0.0005305 0.004431
558 EMBRYONIC HEMOPOIESIS 7 20 0.0005593 0.004632
559 POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS 51 406 0.0005594 0.004632
560 CENTROSOME CYCLE 11 45 0.0005578 0.004632
561 REGULATION OF EPIDERMAL CELL DIFFERENTIATION 11 45 0.0005578 0.004632
562 ACTIVATION OF MAPKK ACTIVITY 12 52 0.000558 0.004632
563 PROTEIN COMPLEX BIOGENESIS 119 1132 0.000562 0.004636
564 PROTEIN COMPLEX ASSEMBLY 119 1132 0.000562 0.004636
565 ANTERIOR POSTERIOR PATTERN SPECIFICATION 29 194 0.000578 0.00476
566 BLOOD VESSEL REMODELING 9 32 0.000585 0.004809
567 REPLACEMENT OSSIFICATION 8 26 0.000608 0.004972
568 REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 31 213 0.000607 0.004972
569 ENDOCHONDRAL OSSIFICATION 8 26 0.000608 0.004972
570 REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY 6 15 0.0006198 0.005024
571 CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS 6 15 0.0006198 0.005024
572 NOSE DEVELOPMENT 6 15 0.0006198 0.005024
573 VENOUS BLOOD VESSEL DEVELOPMENT 6 15 0.0006198 0.005024
574 EPITHELIAL CELL FATE COMMITMENT 6 15 0.0006198 0.005024
575 POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION 13 60 0.0006367 0.005153
576 VESICLE CYTOSKELETAL TRAFFICKING 10 39 0.000658 0.005297
577 NEGATIVE REGULATION OF ENDOTHELIAL CELL MIGRATION 10 39 0.000658 0.005297
578 POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 10 39 0.000658 0.005297
579 REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE 12 53 0.0006706 0.00538
580 NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION 12 53 0.0006706 0.00538
581 REGULATION OF CELLULAR RESPONSE TO STRESS 78 691 0.0006956 0.005571
582 REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 18 100 0.0007125 0.005696
583 MORPHOGENESIS OF EMBRYONIC EPITHELIUM 22 134 0.0007252 0.005788
584 POSITIVE REGULATION OF OSSIFICATION 16 84 0.0007315 0.005828
585 REGULATION OF CELL CYCLE PHASE TRANSITION 42 321 0.0007346 0.005843
586 NEGATIVE REGULATION OF WNT SIGNALING PATHWAY 29 197 0.0007438 0.005906
587 CELLULAR RESPONSE TO ABIOTIC STIMULUS 36 263 0.0007497 0.005942
588 POSITIVE REGULATION OF STEM CELL PROLIFERATION 13 61 0.000752 0.005951
589 INTRINSIC APOPTOTIC SIGNALING PATHWAY 24 152 0.0007594 0.005999
590 DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS 31 216 0.0007704 0.006076
591 RESPONSE TO HYDROGEN PEROXIDE 19 109 0.0007738 0.006092
592 DECIDUALIZATION 7 21 0.0007826 0.00613
593 REGULATION OF GLIAL CELL PROLIFERATION 7 21 0.0007826 0.00613
594 POSITIVE REGULATION OF ADHERENS JUNCTION ORGANIZATION 7 21 0.0007826 0.00613
595 CELLULAR RESPONSE TO EXTERNAL STIMULUS 36 264 0.0008041 0.006254
596 POSITIVE REGULATION OF HEART GROWTH 8 27 0.0008051 0.006254
597 MOTOR NEURON AXON GUIDANCE 8 27 0.0008051 0.006254
598 REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 8 27 0.0008051 0.006254
599 NEGATIVE REGULATION OF OSSIFICATION 14 69 0.0008039 0.006254
600 POSITIVE REGULATION OF CELL MATRIX ADHESION 10 40 0.0008164 0.006331
601 CARDIAC SEPTUM DEVELOPMENT 16 85 0.0008367 0.006457
602 REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION 16 85 0.0008367 0.006457
603 TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER 24 153 0.0008351 0.006457
604 POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 25 162 0.00084 0.006471
605 REGULATION OF APOPTOTIC SIGNALING PATHWAY 46 363 0.0008452 0.0065
606 MULTI ORGANISM REPRODUCTIVE PROCESS 96 891 0.0008629 0.006626
607 NEURON MIGRATION 19 110 0.000868 0.006653
608 NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 18 102 0.0009068 0.00694
609 REGULATION OF FEVER GENERATION 5 11 0.00091 0.006953
610 MORPHOGENESIS OF AN ENDOTHELIUM 6 16 0.0009262 0.007053
611 ATRIOVENTRICULAR VALVE MORPHOGENESIS 6 16 0.0009262 0.007053
612 MUSCLE ORGAN MORPHOGENESIS 14 70 0.0009336 0.007098
613 REGULATION OF KIDNEY DEVELOPMENT 12 55 0.0009532 0.007235
614 POSITIVE REGULATION OF GROWTH 33 238 0.0009752 0.00739
615 NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 53 437 0.001001 0.007574
616 POSITIVE REGULATION OF KIDNEY DEVELOPMENT 10 41 0.001005 0.00759
617 PEPTIDYL AMINO ACID MODIFICATION 91 841 0.001021 0.007699
618 RESPONSE TO INORGANIC SUBSTANCE 57 479 0.001042 0.007845
619 POSITIVE REGULATION OF T CELL PROLIFERATION 17 95 0.001059 0.00795
620 CELL JUNCTION ASSEMBLY 21 129 0.001059 0.00795
621 POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT 7 22 0.001071 0.008022
622 MOVEMENT IN ENVIRONMENT OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 16 87 0.001086 0.008047
623 ENTRY INTO CELL OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 16 87 0.001086 0.008047
624 VIRAL ENTRY INTO HOST CELL 16 87 0.001086 0.008047
625 ENTRY INTO OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 16 87 0.001086 0.008047
626 MOVEMENT IN HOST ENVIRONMENT 16 87 0.001086 0.008047
627 ENTRY INTO HOST 16 87 0.001086 0.008047
628 ENTRY INTO HOST CELL 16 87 0.001086 0.008047
629 REGULATION OF B CELL ACTIVATION 20 121 0.001136 0.008405
630 REGULATION OF CYTOSKELETON ORGANIZATION 59 502 0.00116 0.00857
631 POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 38 289 0.001168 0.008598
632 CELLULAR RESPONSE TO OXIDATIVE STRESS 27 184 0.001166 0.008598
633 CELLULAR RESPONSE TO ACID CHEMICAL 26 175 0.001186 0.008707
634 GLIOGENESIS 26 175 0.001186 0.008707
635 EMBRYONIC CAMERA TYPE EYE DEVELOPMENT 9 35 0.001189 0.008713
636 RESPONSE TO ORGANOPHOSPHORUS 22 139 0.001195 0.00874
637 GLOMERULUS DEVELOPMENT 11 49 0.001198 0.008753
638 PEPTIDYL SERINE MODIFICATION 23 148 0.001206 0.008795
639 REGULATION OF STEM CELL DIFFERENTIATION 19 113 0.001212 0.008822
640 EPITHELIAL CELL MORPHOGENESIS 10 42 0.001227 0.008924
641 LEUKOCYTE PROLIFERATION 16 88 0.001233 0.008934
642 NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 16 88 0.001233 0.008934
643 COGNITION 34 251 0.001241 0.008984
644 CELL MATURATION 21 131 0.001295 0.00934
645 RETINA DEVELOPMENT IN CAMERA TYPE EYE 21 131 0.001295 0.00934
646 RESPONSE TO PURINE CONTAINING COMPOUND 24 158 0.00132 0.009509
647 MAMMARY GLAND ALVEOLUS DEVELOPMENT 6 17 0.001337 0.009571
648 MAMMARY GLAND LOBULE DEVELOPMENT 6 17 0.001337 0.009571
649 REGULATION OF PRI MIRNA TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 6 17 0.001337 0.009571
650 DEFINITIVE HEMOPOIESIS 6 17 0.001337 0.009571
651 REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 8 29 0.001352 0.009634
652 REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS 8 29 0.001352 0.009634
653 REGULATION OF EMBRYONIC DEVELOPMENT 19 114 0.001349 0.009634
654 REGULATION OF ADAPTIVE IMMUNE RESPONSE 20 123 0.001397 0.00991
655 MULTICELLULAR ORGANISMAL SIGNALING 20 123 0.001397 0.00991
656 POST EMBRYONIC DEVELOPMENT 16 89 0.001396 0.00991
NumGOOverlapSizeP ValueAdj. P Value
1 ENZYME BINDING 232 1737 8.152e-17 7.573e-14
2 KINASE BINDING 102 606 1.073e-13 4.983e-11
3 RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING 99 629 1.49e-11 4.475e-09
4 MACROMOLECULAR COMPLEX BINDING 179 1399 1.927e-11 4.475e-09
5 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 61 328 1.851e-10 3.439e-08
6 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING 59 315 2.753e-10 3.694e-08
7 RECEPTOR BINDING 182 1476 2.783e-10 3.694e-08
8 PROTEIN COMPLEX BINDING 126 935 1.006e-09 1.168e-07
9 PROTEIN DOMAIN SPECIFIC BINDING 92 624 2.533e-09 2.615e-07
10 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 45 226 5.066e-09 4.706e-07
11 CYTOSKELETAL PROTEIN BINDING 110 819 1.467e-08 1.239e-06
12 MOLECULAR FUNCTION REGULATOR 162 1353 2.323e-08 1.798e-06
13 REGULATORY REGION NUCLEIC ACID BINDING 109 818 2.618e-08 1.871e-06
14 RIBONUCLEOTIDE BINDING 208 1860 5.142e-08 3.412e-06
15 CALCIUM ION BINDING 95 697 7.228e-08 4.476e-06
16 CELL ADHESION MOLECULE BINDING 37 186 1.174e-07 6.817e-06
17 SH3 DOMAIN BINDING 27 116 2.26e-07 1.235e-05
18 NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY 142 1199 3.493e-07 1.803e-05
19 BINDING BRIDGING 34 173 5.077e-07 2.483e-05
20 PROTEIN KINASE ACTIVITY 86 640 5.576e-07 2.59e-05
21 CHEMOREPELLENT ACTIVITY 11 27 2.666e-06 0.000118
22 SIGNALING ADAPTOR ACTIVITY 19 74 2.89e-06 0.000122
23 PROTEIN SERINE THREONINE KINASE ACTIVITY 63 445 3.332e-06 0.0001311
24 SEQUENCE SPECIFIC DNA BINDING 122 1037 3.388e-06 0.0001311
25 INTEGRIN BINDING 23 105 5.249e-06 0.0001951
26 KINASE ACTIVITY 102 842 6.347e-06 0.0002268
27 ADENYL NUCLEOTIDE BINDING 165 1514 6.675e-06 0.0002297
28 ACTIN BINDING 56 393 9.472e-06 0.0003143
29 TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS 115 992 1.278e-05 0.0004095
30 CORE PROMOTER PROXIMAL REGION DNA BINDING 53 371 1.513e-05 0.0004685
31 METALLOENDOPEPTIDASE ACTIVITY 23 113 1.886e-05 0.0005651
32 DOUBLE STRANDED DNA BINDING 92 764 2.274e-05 0.0006602
33 COLLAGEN BINDING 16 65 3.058e-05 0.0008607
34 GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 44 303 5.248e-05 0.001393
35 PROTEIN TYROSINE KINASE BINDING 14 54 5.114e-05 0.001393
36 GROWTH FACTOR BINDING 23 123 7.649e-05 0.001974
37 GLYCOPROTEIN BINDING 20 101 9.671e-05 0.002428
38 EXTRACELLULAR MATRIX BINDING 13 51 0.0001138 0.002781
39 GLYCOSAMINOGLYCAN BINDING 32 205 0.0001382 0.003292
40 METALLOPEPTIDASE ACTIVITY 30 188 0.0001479 0.003435
41 SEMAPHORIN RECEPTOR BINDING 8 22 0.0001652 0.003742
42 UDP GLYCOSYLTRANSFERASE ACTIVITY 24 139 0.0001964 0.004242
43 TUBULIN BINDING 39 273 0.0001927 0.004242
44 ENZYME REGULATOR ACTIVITY 105 959 0.000282 0.005954
45 CYTOKINE RECEPTOR BINDING 38 271 0.0003374 0.006965
46 ENZYME ACTIVATOR ACTIVITY 58 471 0.0004058 0.008196
47 TRANSCRIPTION FACTOR BINDING 63 524 0.0004463 0.008821
NumGOOverlapSizeP ValueAdj. P Value
1 INTRINSIC COMPONENT OF PLASMA MEMBRANE 219 1649 1.321e-15 3.857e-13
2 MEMBRANE MICRODOMAIN 66 288 1.206e-15 3.857e-13
3 CELL JUNCTION 161 1151 1.722e-13 3.352e-11
4 CELL SURFACE 115 757 3.398e-12 4.961e-10
5 NEURON PROJECTION 134 942 6.637e-12 7.752e-10
6 NEURON PART 165 1265 2.864e-11 2.788e-09
7 PLASMA MEMBRANE PROTEIN COMPLEX 82 510 3.047e-10 2.542e-08
8 MEMBRANE REGION 146 1134 1.089e-09 7.948e-08
9 CELL PROJECTION 208 1786 1.918e-09 1.244e-07
10 GOLGI APPARATUS 175 1445 2.54e-09 1.483e-07
11 RECEPTOR COMPLEX 58 327 3.301e-09 1.752e-07
12 PLASMA MEMBRANE RAFT 25 86 5.369e-09 2.613e-07
13 SOMATODENDRITIC COMPARTMENT 93 650 9.492e-09 4.264e-07
14 ANCHORING JUNCTION 75 489 1.431e-08 5.968e-07
15 SIDE OF MEMBRANE 68 428 1.648e-08 6.415e-07
16 SYNAPSE 102 754 3.469e-08 1.266e-06
17 PERINUCLEAR REGION OF CYTOPLASM 90 642 4.368e-08 1.5e-06
18 PLASMA MEMBRANE RECEPTOR COMPLEX 35 175 2.23e-07 7.235e-06
19 EXTERNAL SIDE OF PLASMA MEMBRANE 42 238 5.438e-07 1.672e-05
20 POSTSYNAPSE 58 378 6.073e-07 1.689e-05
21 DENDRITE 66 451 6.029e-07 1.689e-05
22 CELL BODY 70 494 9.33e-07 2.477e-05
23 INTRACELLULAR VESICLE 145 1259 1.315e-06 3.338e-05
24 EXCITATORY SYNAPSE 36 197 1.477e-06 3.594e-05
25 GOLGI APPARATUS PART 109 893 2.141e-06 4.808e-05
26 PROTEINACEOUS EXTRACELLULAR MATRIX 54 356 2.1e-06 4.808e-05
27 CELL SUBSTRATE JUNCTION 58 398 3.269e-06 7.071e-05
28 EXTRACELLULAR MATRIX 60 426 6.668e-06 0.0001343
29 SYNAPSE PART 79 610 6.568e-06 0.0001343
30 PLASMA MEMBRANE REGION 110 929 7.79e-06 0.0001516
31 ENDOPLASMIC RETICULUM 175 1631 8.703e-06 0.000164
32 CELL CELL JUNCTION 55 383 9.024e-06 0.0001647
33 CELL CELL CONTACT ZONE 16 64 2.484e-05 0.0004372
34 INTERCALATED DISC 14 51 2.545e-05 0.0004372
35 EXTRACELLULAR MATRIX COMPONENT 24 125 3.454e-05 0.0005763
36 GOLGI MEMBRANE 85 703 4e-05 0.0006489
37 VESICLE MEMBRANE 66 512 4.282e-05 0.0006758
38 CELL LEADING EDGE 48 350 0.0001046 0.001608
39 CELL PROJECTION PART 105 946 0.0001698 0.002542
40 AXON 54 418 0.0001945 0.002839
41 ENDOPLASMIC RETICULUM LUMEN 31 201 0.0002175 0.003097
42 ACTIN CYTOSKELETON 56 444 0.0002781 0.003867
43 CYTOPLASMIC VESICLE PART 71 601 0.0003347 0.004546
44 MEMBRANE PROTEIN COMPLEX 110 1020 0.0003595 0.00473
45 ENDOSOME 89 793 0.0003645 0.00473
46 TRANSPORTER COMPLEX 43 321 0.0003896 0.00484
47 ORGANELLE SUBCOMPARTMENT 42 311 0.0003814 0.00484
48 ENDOPLASMIC RETICULUM PART 122 1163 0.0005209 0.006337
49 GOLGI STACK 21 125 0.0006963 0.008299
50 EXTRACELLULAR SPACE 140 1376 0.0007434 0.008683

Over-represented Pathway

NumPathwayPathviewOverlapSizeP ValueAdj. P Value
1 PI3K_Akt_signaling_pathway_hsa04151 57 352 1.221e-07 6.007e-06
2 Cell_adhesion_molecules_.CAMs._hsa04514 31 145 2.311e-07 6.007e-06
3 MAPK_signaling_pathway_hsa04010 45 295 1.249e-05 0.0001933
4 Cytokine_cytokine_receptor_interaction_hsa04060 42 270 1.487e-05 0.0001933
5 Ras_signaling_pathway_hsa04014 37 232 2.696e-05 0.0002237
6 Rap1_signaling_pathway_hsa04015 34 206 2.738e-05 0.0002237
7 Cell_cycle_hsa04110 24 124 3.011e-05 0.0002237
8 HIF_1_signaling_pathway_hsa04066 20 100 8.364e-05 0.0005436
9 Focal_adhesion_hsa04510 31 199 0.0001811 0.001046
10 p53_signaling_pathway_hsa04115 15 68 0.0002034 0.001058
11 FoxO_signaling_pathway_hsa04068 23 132 0.0002302 0.001088
12 ErbB_signaling_pathway_hsa04012 17 85 0.0002779 0.001204
13 ECM_receptor_interaction_hsa04512 16 82 0.0005546 0.002218
14 NF_kappa_B_signaling_pathway_hsa04064 17 95 0.001059 0.003935
15 TNF_signaling_pathway_hsa04668 18 108 0.001782 0.006179
16 Cellular_senescence_hsa04218 23 160 0.003389 0.01086
17 Notch_signaling_pathway_hsa04330 10 48 0.003551 0.01086
18 Hippo_signaling_pathway_hsa04390 22 154 0.004424 0.01278
19 Phospholipase_D_signaling_pathway_hsa04072 21 146 0.004931 0.0135
20 Hippo_signaling_pathway_multiple_species_hsa04392 7 29 0.006041 0.01571
21 cAMP_signaling_pathway_hsa04024 26 198 0.00658 0.01629
22 cGMP_PKG_signaling_pathway_hsa04022 22 163 0.008632 0.0204
23 TGF_beta_signaling_pathway_hsa04350 12 84 0.0304 0.06872
24 Apoptosis_multiple_species_hsa04215 6 33 0.04088 0.08858
25 Jak_STAT_signaling_pathway_hsa04630 19 162 0.05045 0.1032
26 Phagosome_hsa04145 18 152 0.05162 0.1032
27 Adherens_junction_hsa04520 10 72 0.05363 0.1033
28 ABC_transporters_hsa02010 7 45 0.05934 0.1065
29 Regulation_of_actin_cytoskeleton_hsa04810 23 208 0.05941 0.1065
30 Wnt_signaling_pathway_hsa04310 17 146 0.06513 0.1129
31 Sphingolipid_signaling_pathway_hsa04071 14 118 0.07806 0.1309
32 Endocytosis_hsa04144 24 244 0.1478 0.234
33 Gap_junction_hsa04540 10 88 0.1504 0.234
34 AMPK_signaling_pathway_hsa04152 13 121 0.153 0.234
35 Lysosome_hsa04142 13 123 0.1667 0.2476
36 Apelin_signaling_pathway_hsa04371 14 137 0.1863 0.2691
37 Ferroptosis_hsa04216 5 40 0.2015 0.2832
38 Tight_junction_hsa04530 16 170 0.2589 0.3369
39 Calcium_signaling_pathway_hsa04020 17 182 0.2605 0.3369
40 Neuroactive_ligand_receptor_interaction_hsa04080 25 278 0.2653 0.3369
41 Oocyte_meiosis_hsa04114 12 124 0.2656 0.3369
42 Apoptosis_hsa04210 13 138 0.2859 0.3539
43 Signaling_pathways_regulating_pluripotency_of_stem_cells_hsa04550 13 139 0.2947 0.3549
44 Necroptosis_hsa04217 15 164 0.305 0.3549
45 Hedgehog_signaling_pathway_hsa04340 5 47 0.3071 0.3549
46 VEGF_signaling_pathway_hsa04370 6 59 0.3157 0.3569
47 Autophagy_other_hsa04136 3 32 0.4638 0.5132
48 mTOR_signaling_pathway_hsa04150 11 151 0.6445 0.6982
49 Phosphatidylinositol_signaling_system_hsa04070 7 99 0.6665 0.7074
50 Autophagy_animal_hsa04140 9 128 0.6812 0.7084
51 Mitophagy_animal_hsa04137 4 65 0.7602 0.7751
52 Peroxisome_hsa04146 3 83 0.963 0.963

Quest ID: 56fafebca364820663b981f1b703bc34